ATE427322T1 - INITIATOR FOR LIVING RADICAL POLYMERIZATION WITH A FUNCTIONAL GROUP CAPABILITY TO REACT WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREFROM, POLYPETIDE CONJUGATES AND MEDICINAL OBTAINED THEREFROM - Google Patents

INITIATOR FOR LIVING RADICAL POLYMERIZATION WITH A FUNCTIONAL GROUP CAPABILITY TO REACT WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREFROM, POLYPETIDE CONJUGATES AND MEDICINAL OBTAINED THEREFROM

Info

Publication number
ATE427322T1
ATE427322T1 AT04742963T AT04742963T ATE427322T1 AT E427322 T1 ATE427322 T1 AT E427322T1 AT 04742963 T AT04742963 T AT 04742963T AT 04742963 T AT04742963 T AT 04742963T AT E427322 T1 ATE427322 T1 AT E427322T1
Authority
AT
Austria
Prior art keywords
obtained therefrom
comb polymer
initiator
polypetide
conjugates
Prior art date
Application number
AT04742963T
Other languages
German (de)
Inventor
David Haddleton
Francois Lecolley
Lei Tao
Giuseppe Mantovani
Adrian Carmichael
Andrew Steward
Adam Jarvis
Original Assignee
Warwick Effect Polymers Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warwick Effect Polymers Ltd filed Critical Warwick Effect Polymers Ltd
Application granted granted Critical
Publication of ATE427322T1 publication Critical patent/ATE427322T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
    • C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
    • C08F299/022—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polycondensates with side or terminal unsaturations
    • C08F299/024—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polycondensates with side or terminal unsaturations the unsaturation being in acrylic or methacrylic groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
    • C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
    • C08F290/06—Polymers provided for in subclass C08G
    • C08F290/062—Polyethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
    • C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
    • C08F299/022—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polycondensates with side or terminal unsaturations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00—Polymerisation catalysts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00—Living radical polymerisation
    • C08F2438/01—Atom Transfer Radical Polymerization [ATRP] or reverse ATRP

Abstract

The application provides a method of producing a comb polymer comprising the steps of (a) Providing: (i) a plurality of monomers which are linear, branched or star-shaped, substituted or non-substituted, and have an olefinically unsaturated moiety, the olefinically unsaturated moiety being capable of undergoing addition polymerisation; (ii) an initiator compound; the initiator compound comprising a homolytically cleavable bond, (iii) a catalyst capable of catalysing the polymerisation of the monomer, and (b) Causing the catalyst to catalyse, in combination with the initiator, the polymerisation of a plurality of the monomers to produce the comb polymer catalyst and polymers obtainable by the process are also provided. Preferably, the comb polymer is capable of binding proteins and may be produced from monomers which are alkoxy polyethers, such as poly(alkyleneglycol) or polytetrahydrofuran.
AT04742963T 2003-06-20 2004-06-18 INITIATOR FOR LIVING RADICAL POLYMERIZATION WITH A FUNCTIONAL GROUP CAPABILITY TO REACT WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREFROM, POLYPETIDE CONJUGATES AND MEDICINAL OBTAINED THEREFROM ATE427322T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314472.2A GB0314472D0 (en) 2003-06-20 2003-06-20 Polymer

Publications (1)

Publication Number Publication Date
ATE427322T1 true ATE427322T1 (en) 2009-04-15

Family

ID=27637062

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04742963T ATE427322T1 (en) 2003-06-20 2004-06-18 INITIATOR FOR LIVING RADICAL POLYMERIZATION WITH A FUNCTIONAL GROUP CAPABILITY TO REACT WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREFROM, POLYPETIDE CONJUGATES AND MEDICINAL OBTAINED THEREFROM

Country Status (12)

Country Link
US (2) US8436104B2 (en)
EP (2) EP1646661B1 (en)
JP (1) JP5264073B2 (en)
AT (1) ATE427322T1 (en)
AU (1) AU2004249489A1 (en)
CA (1) CA2530001C (en)
DE (1) DE602004020347D1 (en)
DK (1) DK1646661T3 (en)
ES (1) ES2324994T3 (en)
GB (1) GB0314472D0 (en)
WO (1) WO2004113394A2 (en)
ZA (1) ZA200600590B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
WO2006003352A1 (en) * 2004-07-06 2006-01-12 Warwick Effect Polymers Limited Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
CA2620362A1 (en) 2005-09-14 2007-03-22 Ucb Pharma S.A. Comb polymers
SI1988910T1 (en) * 2006-02-28 2018-02-28 Kodiak Sciences Inc. Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
CN100406479C (en) * 2006-05-25 2008-07-30 中国科学院长春应用化学研究所 Beta-diketone monoimine vanadium catalyst containing trifluoromethyl radical for olefinic polymerization and its preparation method and uses
DK2032701T3 (en) 2006-06-23 2014-02-10 Alethia Biotherapeutics Inc Polynucleotides and polypeptides involved in cancer
ITRM20060682A1 (en) * 2006-12-19 2008-06-20 Sicit Chemitech S P A NEW BIODEGRADABLE POLYMER DERIVATIVES
JP5340956B2 (en) * 2006-12-20 2013-11-13 アーケマ・インコーポレイテッド Encapsulation and / or binding of polymers
WO2008098930A1 (en) * 2007-02-14 2008-08-21 Biocompatibes Uk Limited Derivatisation of biological molecules
AU2008303775A1 (en) 2007-09-24 2009-04-02 Noxxon Pharma Ag C5a binding nucleic acids
WO2009053700A1 (en) * 2007-10-23 2009-04-30 Cancer Research Technology Limited Modification of nucleic acid-containing biological entities
WO2009112301A2 (en) * 2008-03-10 2009-09-17 Basf Se Polypeptide agents in the form of conjugates of keratin-binding polypeptides, polymers, and effector molecules, method for the production thereof, and use thereof
US9855291B2 (en) 2008-11-03 2018-01-02 Adc Therapeutics Sa Anti-kidney associated antigen 1 (KAAG1) antibodies
WO2010108657A2 (en) 2009-03-23 2010-09-30 Noxxon Pharma Ag C5a binding nucleic acids and the use thereof
US8067201B2 (en) 2009-04-17 2011-11-29 Bristol-Myers Squibb Company Methods for protein refolding
GB0912160D0 (en) 2009-07-13 2009-08-26 Warwick Effect Polymers Ltd Polymer modified macromolecules
JP2013512294A (en) * 2009-11-27 2013-04-11 ビーエーエスエフ ソシエタス・ヨーロピア Dendritic polyureas for solubilizing active substances with low solubility
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
US8871920B2 (en) 2010-04-21 2014-10-28 Noxxon Pharma Ag Lipid binding nucleic acids
WO2012025251A1 (en) 2010-08-27 2012-03-01 Noxxon Pharma Ag Nucleic acids for treatment of chronic complications of diabetes
DK2613789T3 (en) 2010-09-09 2018-07-23 Noxxon Pharma Ag SDF-1-binding nucleic acids and their use in cancer treatment
EP2633053A1 (en) 2010-10-29 2013-09-04 Noxxon Pharma AG Use of hepcidin binding nucleic acids for depletion of hepcidin from the body
KR20140026357A (en) 2011-01-10 2014-03-05 녹손 파르마 아게 Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
US8937163B2 (en) 2011-03-31 2015-01-20 Alethia Biotherapeutics Inc. Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
CA2852802A1 (en) 2011-10-21 2013-04-25 Noxxon Pharma Ag Glucagon binding nucleic acids
LT2802351T (en) 2012-01-09 2019-06-25 Adc Therapeutics Sa Agents for treating triple negative breast cancer
WO2013104540A1 (en) 2012-01-10 2013-07-18 Noxxon Pharma Ag New c5a binding nucleic acids
BR112014016939A2 (en) 2012-01-10 2019-09-24 Noxxon Pharma Ag nucleic acids that specifically bind to cgrp
JP6463361B2 (en) 2013-09-08 2019-01-30 コディアック サイエンシーズ インコーポレイテッドＫｏｄｉａｋ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． Factor VIII zwitterionic polymer conjugate
EP3065744B1 (en) 2013-11-04 2021-04-21 Noxxon Pharma AG A ccl2 antagonist for use in treating proteinuria
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
CN107208076A (en) 2014-10-17 2017-09-26 科达制药 Butyrylcholine esterase amphoteric ion polymer conjugate
US10098960B2 (en) 2015-04-03 2018-10-16 Ucl Business Plc Polymer conjugate
RU2744860C2 (en) 2015-12-30 2021-03-16 Кодиак Сайенсиз Инк. Antibodies and their conjugates
WO2017178119A1 (en) 2016-04-15 2017-10-19 Noxxon Pharma Ag Method of modulating the number and the distribution of tumor-infiltrating leukocytes in tumors
CN117534764A (en) 2016-06-06 2024-02-09 阿布泽纳(英国)有限公司 Antibodies, uses thereof and conjugates thereof
CN114786731A (en) 2019-10-10 2022-07-22 科达制药股份有限公司 Methods of treating ocular disorders
CN114520325B (en) * 2022-01-07 2023-07-04 惠州锂威新能源科技有限公司 Preparation method of nitrogen-doped carbon material, product, negative electrode plate and secondary battery
WO2023247651A1 (en) 2022-06-21 2023-12-28 TME Pharma AG Methods for treating a tumor in a subject
EP4306640A1 (en) 2022-06-21 2024-01-17 TME Pharma AG Method for treating a tumor in a subject
WO2024022313A1 (en) * 2022-07-25 2024-02-01 南京金斯瑞生物科技有限公司 Method for site-directed synthesis of protein-active molecular conjugate
WO2024026148A1 (en) * 2022-07-29 2024-02-01 University Of Virginia Patent Foundation Compositions comprising linear, star-shaped, and comb-like stapled p9-peg conjugates and methods of use thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT64022A (en) * 1989-04-19 1993-11-29 Enzon Inc Process for producing active polyalkileneoxide carbonates for the modification of polypeptides
US5763548A (en) 1995-03-31 1998-06-09 Carnegie-Mellon University (Co)polymers and a novel polymerization process based on atom (or group) transfer radical polymerization
WO1997001589A1 (en) 1995-06-26 1997-01-16 Basf Aktiengesellschaft New polymer composition for graft copolymers as well as mixtures thereof and thermoplastic compounds containing them
US5807937A (en) * 1995-11-15 1998-09-15 Carnegie Mellon University Processes based on atom (or group) transfer radical polymerization and novel (co) polymers having useful structures and properties
ATE207082T1 (en) * 1996-06-12 2001-11-15 Univ Warwick POLYMERIZATION CATALYST AND PROCESS
EP0910587B1 (en) 1996-07-10 2001-12-12 E.I. Du Pont De Nemours And Company Polymerization with living characteristics
US6214966B1 (en) * 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
TW593347B (en) * 1997-03-11 2004-06-21 Univ Carnegie Mellon Improvements in atom or group transfer radical polymerization
FR2764892B1 (en) 1997-06-23 2000-03-03 Rhodia Chimie Sa PROCESS FOR THE SYNTHESIS OF BLOCK POLYMERS
US20050158273A1 (en) * 1997-09-25 2005-07-21 Harris J. M. Soluble, degradable polyethylene glycol) derivatives for controllable release of bound molecules into solution
GB9725455D0 (en) * 1997-12-02 1998-01-28 Univ Warwick Supported polymerisation catalyst
IL136389A0 (en) 1997-12-18 2001-06-14 Du Pont Polymerization process with living characteristics and polymers made therefrom
AR019322A1 (en) * 1998-06-18 2002-02-13 Smithkline Beecham Corp SULFONYL DERIVATIVES REPLACED BY HETEROCICLO-ETANODIONANILINA REPLACED BY HETEROCICLO, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE FOR LAMANUFACTURE OF A MEDICINAL PRODUCT
JP4231548B2 (en) * 1998-12-28 2009-03-04 日東電工株式会社 Pressure-sensitive adhesive composition and method for producing the same
WO2000056795A1 (en) * 1999-03-23 2000-09-28 Carnegie Mellon University Catalytic processes for the controlled polymerization of free radically (co)polymerizable monomers and functional polymeric systems prepared thereby
GB0014225D0 (en) 2000-06-09 2000-08-02 Univ Warwick Polymerisation initiator and use
KR100396983B1 (en) 2000-07-29 2003-09-02 이강춘 Highly reactive branched polymer and proteins or peptides conjugated with the polymer
TW593427B (en) 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
WO2003032990A2 (en) 2001-10-18 2003-04-24 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
EP1446438A2 (en) 2001-11-07 2004-08-18 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates
US20030171285A1 (en) 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
US7144978B2 (en) * 2002-01-15 2006-12-05 Pan Asia Bio Co., Ltd. Multidrop tree branching functional polyethylene glycol, methods of preparing and using same
ATE371680T1 (en) * 2002-01-16 2007-09-15 Biocompatibles Uk Ltd POLYMER CONJUGATES
DE10228103A1 (en) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungicidal active ingredient combinations
CA2498167C (en) 2002-09-09 2012-03-20 Nektar Therapeutics Al, Corporation Water-soluble polymer alkanals
US6992217B2 (en) * 2002-12-11 2006-01-31 3M Innovative Properties Company Ring-opened azlactone initiators for atom transfer radical polymerization
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
PT1656410E (en) 2003-07-22 2010-06-11 Nektar Therapeutics Method for preparing functionalized polymers from polymer alcohols

Also Published As

Publication number Publication date
DK1646661T3 (en) 2009-07-20
EP1646661B1 (en) 2009-04-01
GB0314472D0 (en) 2003-07-23
WO2004113394A2 (en) 2004-12-29
EP1646661A2 (en) 2006-04-19
JP5264073B2 (en) 2013-08-14
US20130295040A1 (en) 2013-11-07
WO2004113394A3 (en) 2005-05-06
CA2530001C (en) 2011-03-01
EP2161291A2 (en) 2010-03-10
ZA200600590B (en) 2007-07-25
US9200104B2 (en) 2015-12-01
DE602004020347D1 (en) 2009-05-14
US20080300348A1 (en) 2008-12-04
JP2007516302A (en) 2007-06-21
AU2004249489A2 (en) 2004-12-29
AU2004249489A1 (en) 2004-12-29
CA2530001A1 (en) 2004-12-29
ES2324994T3 (en) 2009-08-21
US8436104B2 (en) 2013-05-07

Similar Documents

Publication Publication Date Title
ATE427322T1 (en) INITIATOR FOR LIVING RADICAL POLYMERIZATION WITH A FUNCTIONAL GROUP CAPABILITY TO REACT WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREFROM, POLYPETIDE CONJUGATES AND MEDICINAL OBTAINED THEREFROM
DE60019427D1 (en) METHOD FOR THE PRODUCTION OF CYCLOOLEFIN POLYMERS AND POLYMERIZABLE CYCLOOLEFINES
de Espinosa et al. Synthesis of star-and block-copolymers using ADMET: head-to-tail selectivity during step-growth polymerization
ATE428688T1 (en) FUNCTIONAL MONOMERS FOR MOLECULAR RECOGNITION AND CATALYSIS
ATE124709T1 (en) LACTONE POLYMERIZATION CATALYSED BY YTTRIUM AND RARE EARTH COMPOUNDS.
RU2007102285A (en) POLYMER-CONTAINING COMPOSITION, ITS PRODUCTION AND USE
WO2008019100A3 (en) Living radical polymerization of activated and nonactivated monomers containing electron-withdrawing side groups
DE502006008732D1 (en) METHOD FOR PRODUCING POLYISOBUTES
DE69311143T2 (en) Process for the production of star or network multiblock polycondensates by coupling di- or multi-aldehydes and polycondensates produced therewith
ATE269306T1 (en) N-ALKOXY-4,4-DIOXY-POLYALKYL-PIPERIDINE COMPOUNDS WITH GLYCIDYL OR ALKYLOXYCARBONYL GROUPS AS FUNCTIONAL INITIATORS FOR CONTROLLED RADICAL POLYMERIZATION
DE60330815D1 (en) Polyorganosilylated carboxylate monomers or polymers thereof and process for their preparation
CA2707131A1 (en) Cross-linkable vinylester-copolymers and use thereof as low-profile-additives
Zhang et al. Photo-controlled one-pot strategy for the synthesis of asymmetric three-arm star polymers
DE60315667D1 (en) METHOD FOR PRODUCING A CATALYST FOR THE POLYMERIZATION OF ALIPHATIC POLYCARBONATE AND METHOD FOR POLYMERIZING ALIPHATIC POLYCARBONATE THEREWITH
ES2118102T3 (en) PROCEDURE FOR PREPARING POLYMERS AND MOLDING COMPOSITIONS BASED ON THEM.
BRPI0417245A (en) process to produce polymers
DE50210243D1 (en) METHOD FOR PRODUCING POLYMER COMPOSITIONS WITH REDUCED HALOGEN CONTENT, HALOGEN REDUCED POLYMER COMPOSITIONS, AND USE OF THIS COMPOSITION
ATE279452T1 (en) CATALYST FOR ADDITION POLYMERIZATION AND METHOD FOR PRODUCING AN ADDITION POLYMER USING THIS CATALYST
EP1000954A4 (en) Polymers and process for producing polymers
ATE417870T1 (en) METHOD FOR PRODUCING HIGH BULK DENSITY CYCLOOLEFIN POLYMERS AND CYCLOOLEFIN POLYMER PRODUCED THEREFROM
WO2004078810A3 (en) Polymer products
ATE310764T1 (en) IMPROVED METHOD FOR PRODUCING POLYTETRAHYDROFURAN
ATE339967T1 (en) MOLECULAR LABELED MICROSPHERES PRODUCED BY PRECIPITATION POLYMERIZATION
ATE122361T1 (en) ETHENE (CO)POLYMER SUITABLE FOR CROSSLINKING, ITS PRODUCTION AND CROSSLINKING.
DE60010400D1 (en) Solid catalyst component and catalyst for the polymerization of olefins, process for producing an olefin polymer and process for producing the solid catalyst component for olefin polymerization

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties